Reaction Details |
| Report a problem with these data |
Target | B2 bradykinin receptor |
---|
Ligand | BDBM50403371 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_40422 (CHEMBL652637) |
---|
Ki | 0.064±n/a nM |
---|
Citation | Amblard, M; Daffix, I; Bedos, P; Bergé, G; Pruneau, D; Paquet, JL; Luccarini, JM; Bélichard, P; Dodey, P; Martinez, J Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety. J Med Chem42:4185-92 (1999) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
B2 bradykinin receptor |
---|
Name: | B2 bradykinin receptor |
Synonyms: | B2 BRADYKININ | B2 bradykinin receptor | B2R | BDKRB2 | BK-2 receptor | BKR2 | BKRB2_HUMAN | Bradykinin B2 receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 44467.17 |
Organism: | Homo sapiens (Human) |
Description: | B2 BRADYKININ BDKRB2 HUMAN::P30411 |
Residue: | 391 |
Sequence: | MFSPWKISMFLSVREDSVPTTASFSADMLNVTLQGPTLNGTFAQSKCPQVEWLGWLNTIQ
PPFLWVLFVLATLENIFVLSVFCLHKSSCTVAEIYLGNLAAADLILACGLPFWAITISNN
FDWLFGETLCRVVNAIISMNLYSSICFLMLVSIDRYLALVKTMSMGRMRGVRWAKLYSLV
IWGCTLLLSSPMLVFRTMKEYSDEGHNVTACVISYPSLIWEVFTNMLLNVVGFLLPLSVI
TFCTMQIMQVLRNNEMQKFKEIQTERRATVLVLVVLLLFIICWLPFQISTFLDTLHRLGI
LSSCQDERIIDVITQIASFMAYSNSCLNPLVYVIVGKRFRKKSWEVYQGVCQKGGCRSEP
IQMENSMGTLRTSISVERQIHKLQDWAGSRQ
|
|
|
BDBM50403371 |
---|
n/a |
---|
Name | BDBM50403371 |
Synonyms: | Firazyr | HOE-140 | ICATIBANT |
Type | Small organic molecule |
Emp. Form. | C59H89N19O13S |
Mol. Mass. | 1304.522 |
SMILES | [#7]-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-1-[#6]-[#6@H](-[#8])-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-c1cccs1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#8])-[#6](=O)-[#7]-1-[#6]-c2ccccc2-[#6]-[#6@@H]-1-[#6](=O)-[#7]-1-[#6@H]-2-[#6]-[#6]-[#6]-[#6]-[#6@H]-2-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](-[#8])=O |
Structure |
|